Maine U.S. Sen. Susan Collins nailed it in her assessment of President Donald Trump. Readers weigh in on many issues in today's letters.

Sen. Susan Collins (R-ME) announced on Thursday that she will vote against Kash Patel to lead the FBI. Collins joined Sen. Mitch McConnell (R-KY) in publicly opposing Patel, one of President Donald Trump’s most controversial nominees.

Key moderate Republican Sen. Susan Collins announced she is voting against Kash Patel to be director of the FBI under President Donald Trump.

He told me he believed in the efficacy of the polio vaccine, and said he would help restore Americans’ confidence in vaccines and our health agencies,” Sen. Collins said in a

National political insiders and observers are already eyeing Sen. Susan Collins' bid for reelection in 2026 as a potentially pivotal race — and a very expensive one. One prominent national political forecaster said last week that,

Sen. Susan Collins blasted the Trump administration’s recent cap on indirect costs for grants issued by the National Institute of Health and revealed that she had a call with Health and

Sen. Collins is breaking ranks with many in her party by criticizing the cuts across several federal agencies.

Sen. Susan Collins (R-Maine) said she would vote against the nomination of Kash Patel to serve as FBI director, citing a string of political comments that call into question his ability to

"There's jokes on Capitol Hill that today is another day that Susan Collins is 'concerned.'" said Casey Burgat, a professor of legislative affairs at George Washington University.

The National Institutes of Health directive to cap "indirect costs" for medical research grants drew swift criticism.

Surely, moderate Republicans like Sen. Susan Collins—who is up for reelection next year in the reliably blue state of Maine—would consider Kennedy and Gabbard too treacherous to swallow? Nope. Collins voted to confirm both nominees,

"As I have stated previously, these initiatives raise the specter that adverse actions could be taken against FBI employees - including special agents in the field"